Type 2 immunity to the rescue: enhancing antitumor immunity for skin cancer prevention
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci188018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Matthew D Vesely und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, and. Hauptthemen laut MEDLINE: Skin Neoplasms, Keratinocytes, Carcinoma, Squamous Cell, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, and.
- Department of Surgery, Division of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
Förderung
- NIAMS NIH HHS
Zitieren
APA
Vesely, M. D., & Christensen, S. R. (2025). Type 2 immunity to the rescue: enhancing antitumor immunity for skin cancer prevention. Journal of Clinical Investigation. https://doi.org/10.1172/jci188018
Vancouver
Vesely MD, Christensen SR. Type 2 immunity to the rescue: enhancing antitumor immunity for skin cancer prevention. Journal of Clinical Investigation. 2025. doi:10.1172/jci188018
BibTeX
@article{Vesely2025,
author = {Vesely, Matthew D and Christensen, Sean R},
title = {Type 2 immunity to the rescue: enhancing antitumor immunity for skin cancer prevention},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci188018}
}
EUVIMED